Sciformix to launch labelling service

Published: 5-Mar-2015
Packaging Regulatory

Includes ready to use technology solutions to support workflow, content and process control


Sciformix, a leading Scientific Process Organisation (SPO), will offer a new labelling platform from the end of this month.

The platform is a fully integrated managed service offering processes and technology that cover the entire labelling process from signal/change triggers to package implementation. It includes performance, quality and compliance metrics and pre-configured, ready-to-use technology solutions to support workflow, content management and process control.

Sciformix says benefits of the new platform include efficiency and scale to accelerate label updates, deployment and implementation.

Manish Soman, President and CEO, Sciformix Corporation, said: 'Sciformix’s long-term strategy focuses on evolving and enhancing our service and technology offerings for our clients, broadening our global reach, and growing and diversifying our customer base. Being able to offer this end-to-end labelling platform supports all of these objectives.'

He added: 'We have formed strategic partnerships with niche labelling solution providers and act as an integrator of technology enablers by leveraging our labelling, regulatory and IT expertise.'

With operations in North America, Europe and Asia, Sciformix offers comprehensive global labelling services, including labelling content development and lifecycle management, operational support and workflow management, regional labelling support, and artwork/package component labelling management.

The new platform will be presented at the Marcus Evans 3rd Annual Labelling Compliance Conference in Boston, MA, US, from 25–26 March.

  • Companies:
  • Sciformix Corporation
See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

EudraVigilance: what’s changed?

Read more
In May 2017, the updates to the EudraVigilance system were approved for release and the changes went into effect on 22 November 2017, implemented by the European Medicines Agency (EMA)

Trending Articles

  1. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  3. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  4. Gerresheimer acquires Bormioli Pharma Group through Blitz LuxCo Sarl merger Gerresheimer and Bormioli Pharma will merge to provide the biotech and pharmaceutical industries with primary packaging solutions, dosing systems, closure solutions and accessories
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

EudraVigilance: what’s changed?

In May 2017, the updates to the EudraVigilance system were approved for release and the changes went into effect on 22 November 2017, implemented by the European Medicines Agency (EMA)
Media

Automated and integrated drug safety database solution

Through its collaboration with Oracle Health Sciences, Sciformix is able to offer its customers a fully automated and integrated safety database solution, allowing easy reporting and analytics for improving the quality and efficiency of drug safety operations
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Labelling and generics: who is accountable?

Bindu Narang, Director of Regulatory Affairs and Scientific Writing, Sciformix Corporation, considers the impact of proposed US FDA labelling regulations on the generic drugs sector
Regulatory

Sciformix expands into Europe with new office in Manchester, UK

European office to support growth in client delivery and customer backup
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Outsourcing clinical trial safety data management

Outsourcing clinical trial safety data is a relatively recent trend that requires confidence in the selected partner. Supriya Desai, Director, Medical Safety Operations, and Suhasini Sharma, Director, Medical Affairs, Sciformix Corporation consider what to look for
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

A successful path to fulfilling pharmacovigilance obligations

As the number of innovator pharmaceutical and generic manufacturer partnerships grow, the lines of responsibility for meeting pharmacovigilance requirements can get blurred. Chitra Lele, of Sciformix Corporation, looks at routes to managing the issue
Regulatory

Accelerating and enhancing toxicology assessments

Infographic guides users through ToxHQ’s speedy assessment features
Subscribe now